On October 31, Profectus BioSciences, Inc. announced it has received millions of dollars to develop an Ebola vaccine.

The Pentagon awarded the contract through its Medical Countermeasure Systems-Joint Vaccine Acquisition Program, a program that develops and stockpiles vaccines to be used on soldiers.